Loading provider…
Loading provider…
Hematology & Oncology Physician in Bakersfield, CA
NPI: 1013988583Primary Practice Location
Cbcc Surgery Center, LLC
6501 Truxtun Avenue, Bakersfield, CA
Primary Employer
Comprehensive Blood & Cancer Center
cbccusa.com
HQ Phone
Get MD Kota's Phone Numberphone_androidMobile
Get MD Kota's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardCA State Medical License
CA State Medical License
1993 - 2027

American Board of Internal Medicine
Internal Medicine

American Board of Internal Medicine
Hematology

American Board of Internal Medicine
Medical Oncology
Los Angeles County-Harbor-UCLA Medical Center 1
Fellowship • Hematology and Medical Oncology
1993 - 1996
University of North Dakota
Residency • Internal Medicine
1991 - 1993
Lincoln Medical and Mental Health Center
Internship • Internal Medicine
1990 - 1991
Osmania Medical College NTR UHS
Medical School
Until 1981
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99213Established patient office or other outpatient visit, typically 15 minutes | 433 | 678 |
| 2 | 99204New patient office or other outpatient visit, 45-59 minutes | 56 | 56 |
Gender influence on weight-loss pattern and survival of nonsmall cell lung carcinoma patients
Authors: Melanie Palomares, Rowan Chlebowski
Journal: Cancer
Gender influence on weight-loss pattern and survival of nonsmall cell lung
Authors: Melanie R. Palomares, James Sayre, Kota C. Shekar, Linda Lillington, Rowan
Publication Date: 1996-11
Lead Sponsor: Oncotherapeutics
Collaborators: Incyte Corporation
Intervention / Treatment: DRUG: Lenalidomide, DRUG: Methylprednisolone, DRUG: Ruxolitinib Oral Tablet [Jakafi]
Lead Sponsor: Eli Lilly and Company
Collaborators: ARMO BioSciences
Intervention / Treatment: BIOLOGICAL: Pegilodecakin, DRUG: FOLFOX